These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations. Torres A; Mouton JW; Pea F Clin Pharmacokinet; 2016 Dec; 55(12):1507-1520. PubMed ID: 27272266 [TBL] [Abstract][Full Text] [Related]
5. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? Eachempati SR; Hydo LJ; Shou J; Barie PS J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237 [TBL] [Abstract][Full Text] [Related]
6. Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia. Wood GC Expert Rev Anti Infect Ther; 2011 Nov; 9(11):993-1000. PubMed ID: 22029519 [TBL] [Abstract][Full Text] [Related]
7. What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance. Udy AA; Roberts JA; De Waele JJ; Paterson DL; Lipman J Int J Antimicrob Agents; 2012 Jun; 39(6):455-7. PubMed ID: 22483562 [No Abstract] [Full Text] [Related]
8. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops. Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560 [TBL] [Abstract][Full Text] [Related]
9. Controversies and Evolving Concepts in Hospital-Acquired Pneumonia. Chastre J; Luyt CE Semin Respir Crit Care Med; 2017 Jun; 38(3):235-236. PubMed ID: 28578547 [No Abstract] [Full Text] [Related]
10. Pharmacokinetic/Pharmacodynamic Optimization of Hospital-Acquired and Ventilator-Associated Pneumonia: Challenges and Strategies. Abouelhassan YP; Nicolau D Semin Respir Crit Care Med; 2022 Apr; 43(2):175-182. PubMed ID: 35088402 [TBL] [Abstract][Full Text] [Related]
11. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance. Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955 [TBL] [Abstract][Full Text] [Related]
12. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management. Barbier F; Andremont A; Wolff M; Bouadma L Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477 [TBL] [Abstract][Full Text] [Related]
14. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study. Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137 [No Abstract] [Full Text] [Related]
15. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance. Werarak P; Kiratisin P; Thamlikitkul V J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567 [TBL] [Abstract][Full Text] [Related]
16. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit. Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613 [TBL] [Abstract][Full Text] [Related]